Total PSA (Prostate-Specific Antigen, Total)
Main screening test for detection of prostate gland diseases. Used for early prostate cancer detection. Applied for diagnosis of benign prostate hyperplasia and prostatitis. Prescribed for monitoring treatment efficacy and post-surgical or post-medical intervention monitoring. Recommended as part of preventive examination for men over 40.
What the test evaluates:
- Total PSA level in blood serum
- Prostate gland functional condition
- Risk of benign or malignant prostate processes
Biomaterial: Venous blood
- Draw blood fasting
- Abstain from ejaculation 48 hours before
- Avoid prostate massage, transrectal ultrasound, and cystoscopy 5-7 days before
Medications:
- Prostate treatment drugs (5-alpha-reductase inhibitors) may reduce PSA level
- Inform physician of all medications taken
Recommended for:
- Urologist — with suspected prostate adenoma, prostatitis, or prostate cancer
- Oncologist — for diagnosis, extent assessment, and treatment monitoring
- General practitioner — with urination disorders, lower abdominal pain, weak urinary stream
- Men over 40 — for preventive oncological screening
Important: PSA level evaluated considering patient age, clinical symptoms, and instrumental study data.
Normal: PSA within age norm; no active pathological process signs in prostate
Deviations: elevated PSA may indicate benign prostate hyperplasia, prostatitis, or prostate cancer; significant or progressive elevation requires additional examination (free PSA, PHI index, ultrasound, biopsy); urologist or oncologist consultation required.
Result on the day of the request
